Cell-based methods for ex vivo evaluation of human endothelial biology

Cardiovascular Research

Volumn 87, Issue 1, 2010, Pages 12-21

  Fadini, Gian Paolo ^a   Avogaro, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Angio arteriogenesis; Cell culture isolation; Endothelial function; Immunology; Stem cells

Indexed keywords

ANTIGEN EXPRESSION; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; CELL ISOLATION; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE REGENERATION; VASCULAR ENDOTHELIUM; BIOPSY; CELL SEPARATION; CULTURE TECHNIQUE; FLOW CYTOMETRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REPRODUCIBILITY;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; BIOPSY; CELL CULTURE TECHNIQUES; CELL SEPARATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; STEM CELLS;

EID: 77955161542     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq119     Document Type: Review

References (95)

1. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
2. Griendling KK, Alexander RW. Endothelial control of the cardiovascular system: recent advances. FASEB J 1996;10:283-292.
3. Avogaro A, de Kreutzenberg SV, Fadini G. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract 2008;82(Suppl. 2): S94-S101.
4. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
5. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
6. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 2005;68:26-36.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1990;362:801.
8. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-165.
9. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 2005;568: 357-369.
10. Hijmering ML, Stroes ES, Pasterkamp G, Sierevogel M, Banga JD, Rabelink TJ. Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis 2001;157:369-373.
11. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:1978-1986.
12. Polykandriotis E, Arkudas A, Horch RE, Sturzl M, Kneser U. Autonomously vascular-ized cellular constructs in tissue engineering: opening a new perspective for biomedi-cal science. J Cell Mol Med 2007;11:6-20.
13. Strijbos MH, Verhoef C, Gratama JW, Sleijfer S. On the origin of (CD105+) circulating endothelial cells. Thromb Haemost 2009;102:347-351.
14. Hladovec J. Circulating endothelial cells as a sign of vessel wall lesions. Physiol Bohemo-slov 1978;27:140-144.
15. Mariucci S, Rovati B, Chatzileontiadou S, Bencardino K, Manzoni M, Delfanti S et al. A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells. Scand J Clin Lab Invest 2009;69:433-438.
16. Martin-Padura I, Bertolini F. Circulating endothelial cells as biomarkers for angiogen-esis in tumor progression. Front Biosci (Schol Ed) 2009;1:304-318.
17. Boos CJ, Lip GY, Blann AD. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006;48:1538-1547.
18. McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 2005;48:345-350.
19. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003; 361:206-210.
20. Strijbos MH, Landburg PP, Nur E, Teerlink T, Leebeek FW, Rijneveld AW et al. Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood Cells Mol Dis 2009;43:63-67.
21. Boos CJ, Mayr FB, Lip GY, Jilma B. Endotoxemia enhances circulating endothelial cells in humans. J Thromb Haemost 2006;4:2509-2511.
22. Boos CJ, Soor SK, Kang D, Lip GY. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. Eur Heart J 2007;28:1092-1101.
23. Woywodt A, Blann AD, Kirsch T, Erdbruegger U, Banzet N, Haubitz M et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost 2006;4:671-677.
24. Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Faé I, Waclavicek M et al. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 1997; 158:2107-2115.
25. Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, Desouches C et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 2005;94:1270-1279.
26. Mancuso P, Antoniotti P, Quarna J, Calleri A, Rabascio C, Tacchetti C et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 2009;15:267-273.
27. Van Wijk MJ, Van Bavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277-287.
28. van Ierssel SH, Van Craenenbroeck EM, Conraads VM, Van Tendeloo VF, Vrints CJ, Jorens PG et al. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation storage alter with the phenotype studied. Thromb Res 2010;125:332-339.
29. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003;41: 211-217.
30. Bernard S, Loffroy R, Serusclat A, Boussel L, Bonnefoy E, Thevenon C et al. Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis 2009;203:429-435.
31. Ferreira AC, Peter AA, Mendez AJ, Jimenez JJ, Mauro LM, Chirinos JA et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 2004;110:3599-3603.
32. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005;16:3381-3388.
33. Simoncini S, Njock MS, Robert S, Camoin-Jau L, Sampol J, Harle JR et al. TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation. Circ Res 2009; 104:943-951.
34. Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 2002;22:101-107.
35. Abid Hussein MN, Boing AN, Biro E, Hoek FJ, Vogel GM, Meuleman DG et al. Phos-pholipid composition of in vitro endothelial microparticles and their in vivo thrombo-genic properties. Thromb Res 2008;121:865-871.
36. Leroyer AS, Ebrahimian TG, Cochain C, Recalde A, Blanc-Brude O, Mees B et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 2009;119:2808-2817.
37. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
38. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008;197:496-503.
39. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109-1118.
40. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006; 27:2247-2255.
41. Fadini GP, de Kreutzenberg S, Agostini C, Boscaro E, Tiengo A, Dimmeler S et al. Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis 2009;207:213-219.
42. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endo-thelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
43. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-2760.
44. Rohde E, Malischnik C, Thaler D, Maierhofer T, Linkesch W, Lanzer G et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006;24:357-367.
45. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
46. Leor J, Marber M. Endothelial progenitors: a new Tower of Babel? J Am Coll Cardiol 2006;48:1588-1590.
47. Fadini GP, Albiero M, Cignarella A, Bolego C, Pinna C, Boscaro E et al. Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clin Sci (Lond) 2009; 117:355-364.
48. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004;35:2378-2384.
49. Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002;22:1567-1572.
50. Werner N, Wassmann S, Ahlers P, Schiegl T, Kosiol S, Link A et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007;102:565-571.
51. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008;28:997-1004.
52. Miura M, Numaguchi Y, Ishii M, Kubota R, Takeuchi T, Imamura A et al. Differentiation capacity of endothelial progenitor cells correlates with endothelial function in healthy young men. Circ J 2009;73:1324-1329.
53. Blann AD, Pretorius A. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins? Atherosclerosis 2006;188:12-18.
54. Rodriguez-Ayala E, Yao Q, Holmen C, Lindholm B, Sumitran-Holgersson S, Stenvinkel P. Imbalance between detached circulating endothelial cells and endothelial progenitor cells in chronic kidney disease. Blood Purif 2006;24:196-202.
55. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108: 457-463.
56. Silvestre JS, Gojova A, Brun V, Potteaux S, Esposito B, Duriez M et al. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 2003;180:2839-2842.
57. George J, Afek A, Abashidze A, Shmilovich H, Deutsch V, Kopolovich J et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005;25:2636-2641.
58. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 2006;37:2277-2282.
59. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculo-pathy. Arterioscler Thromb Vasc Biol 2006;26:2140-2146.
60. Chen MC, Chen CJ, Yang CH, Liu WH, Fang CY, Hsieh YK et al. Relationship of the percentage of circulating endothelial progenitor cell to the severity of coronary artery disease. Heart Vessels 2008;23:47-52.
61. George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 2003;23:e57-e60.
62. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 2007;115:553-561.
63. Tsai S, Butler J, Rafii S, Liu B, Kent KC. The role of progenitor cells in the development of intimal hyperplasia. J Vasc Surg 2009;49:502-510.
64. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubuliza-tion of circulating bone marrow-derived cells. Blood 2005;105:1068-1077.
65. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73-91.
66. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
67. Yoder MC, Ingram DA. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol 2009;16:269-273.
68. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-685.
69. Heil M, Ziegelhoeffer T, Mees B, Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth. Bone marrow delivers software not hardware. Circ Res 2004;94:573-574.
70. Wickersheim A, Kerber M, de Miguel LS, Plate KH, Machein MR. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int J Cancer 2009;125:1771-1777.
71. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005;106:1525-1531.
72. Fadini GP, Albiero M, Boscaro E, Agostini C, Avogaro A. Endothelial progenitor cells as resident accessory cells for post-ischemic angiogenesis. Atherosclerosis 2009;204: 20-22.
73. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM et al. Soluble factors released by endothelial progenitor cells promote migration of endo-thelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005;39:733-742.
74. Botta R, Gao E, Stassi G, Bonci D, Pelosi E, Zwas D et al. Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J 2004;18:1392-1394.
75. Friedlander M, Dorrell MI, Ritter MR, Marchetti V, Moreno SK, El-Kalay M et al. Progenitor cells and retinal angiogenesis. Angiogenesis 2007;10:89-101.
76. Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008;13:193-205.
77. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004;287:C572-C579.
78. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
79. Lev EI, Kleiman NS, Birnbaum Y, Harris D, Korbling M, Estrov Z. Circulating endo-thelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. J Vasc Res 2005;42:408-414.
80. Matsuo Y, Imanishi T, Hayashi Y, Tomobuchi Y, Kubo T, Hano T et al. The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease. Intern Med 2008;47:127-134.
81. Fadini GP, Agostini C, Boscaro E, Avogaro A. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome. Metab Syndr Relat Disord 2009;7:5-10.
82. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F et al. Circulating endo-thelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005;45:1449-1457.
83. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006;187:423-432.
84. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 2004;107:273-280.
85. Delva P, Degan M, Vallerio P, Arosio E, Minuz P, Amen G et al. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 2007;25:127-132.
86. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007;194:46-54.
87. Feng L, Stern DM, Pile-Spellman J. Human endothelium: endovascular biopsy and molecular analysis. Radiology 1999;212:655-664.
88. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007;100:174-190.
89. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007;100:158-173.
90. Colombo PC, Ashton AW, Celaj S, Talreja A, Banchs JE, Dubois NB et al. Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. J Appl Physiol 2002;92:1331-1338.
91. Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 2007;100: 1659-1666.
92. Yu SY, Song YM, Li AM, Yu XJ, Zhao G, Song MB et al. Isolation and characterization of human coronary artery-derived endothelial cells in vivo from patients undergoing percutaneous coronary interventions. J Vasc Res 2009;46:487-494.
93. Onat D, Jelic S, Schmidt AM, Pile-Spellman J, Homma S, Padeletti M et al. Vascular endothelial sampling and analysis of gene transcripts: a new quantitative approach to monitor vascular inflammation. J Appl Physiol 2007;103:1873-1878.
94. Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A et al. Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 2007;50: 2156-2163.
95. Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F. Circulating endo-thelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med 2009;13:454-471.